Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
Aim. Based on scientific literature data, to evaluate the effectiveness of the use of immune checkpoint inhibitors (ICI) in the treatment of non-small cell lung cancer (NSCLC). Materials and methods. To analyze the results of clinical trials of NSCLC treatment with immune checkpoint inhibitors....
Main Authors: | O. P. Kolesnik, V. V. Mykhailychenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2021-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/216471/232320 |
Similar Items
-
Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
by: Sung Won Lim, et al.
Published: (2019-01-01) -
Clinical Development of Immune Checkpoint Inhibitors in Patients with Small Cell Lung Cancer
by: Shuang ZHANG, et al.
Published: (2017-09-01) -
The landscape of immune checkpoint inhibitor therapy in advanced lung cancer
by: Chengdi Wang, et al.
Published: (2021-08-01) -
High mortality and poor treatment efficacy of immune checkpoint inhibitors in patients with severe grade checkpoint inhibitor pneumonitis in non‐small cell lung cancer
by: Mari Tone, et al.
Published: (2019-10-01) -
Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
by: Yasuhiro Chikaishi, et al.
Published: (2021-03-01)